Literature DB >> 16362815

Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin.

J L Chan1, V Stoyneva, T Kelesidis, P Raciti, C S Mantzoros.   

Abstract

AIMS/HYPOTHESIS: Peptide YY (PYY) is a gut-derived hormone that has been shown to reduce short-term food intake in animals and humans. It has been proposed that deficiency of PYY contributes to obesity in humans. However, the physiology of PYY regulation by factors such as caloric restriction, or by other molecules important in energy homeostasis, e.g. leptin, remains to be fully elucidated.
MATERIALS AND METHODS: We evaluated the effect on PYY levels of: (1) caloric ingestion (a mixed meal) in five healthy normal-weight subjects; (2) fasting for 2 or 3 days in eight lean men and seven lean women respectively; and (3) recombinant human leptin administration at physiological replacement and pharmacological doses.
RESULTS: PYY levels increased 50% after a mixed meal (p=0.01), and short-term complete fasting for 2 or 3 days decreased leptin and PYY levels to 20-30% and 40-60% of baseline, respectively (both p<0.05). However, recombinant human leptin administration at physiological doses to restore the fasting-induced decrease of leptin levels and at pharmacological doses over the short term had no effect on PYY levels. CONCLUSIONS/
INTERPRETATION: PYY increases after meal ingestion and decreases after fasting in a manner consistent with a meal-related signal of energy homeostasis. Importantly, circulating levels of this gut-secreted molecule are independent of regulation by leptin over the short term. These findings contribute towards our understanding of the homeostatic systems that regulate appetite in humans, including the possible redundancy of gastrointestinally secreted and adipocyte-secreted signals. This may be of importance for the future development of medications to treat obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362815     DOI: 10.1007/s00125-005-0041-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  Physiology: does gut hormone PYY3-36 decrease food intake in rodents?

Authors:  M Tschöp; T R Castañeda; H G Joost; C Thöne-Reineke; S Ortmann; S Klaus; M M Hagan; P C Chandler; K D Oswald; S C Benoit; R J Seeley; K P Kinzig; T H Moran; A G Beck-sickinger; N Koglin; R J Rodgers; J E Blundell; Y Ishii; A H Beattie; P Holch; D B Allison; K Raun; K Madsen; B S Wulff; C E Stidsen; M Birringer; O J Kreuzer; M Schindler; K Arndt; K Rudolf; M Mark; X Y Deng; D C Whitcomb; H Halem; J Taylor; J Dong; R Datta; M Culler; S Craney; D Flora; D Smiley; M L Heiman; D C Withcomb
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

Review 2.  The role of leptin in human obesity and disease: a review of current evidence.

Authors:  C S Mantzoros
Journal:  Ann Intern Med       Date:  1999-04-20       Impact factor: 25.391

3.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

4.  Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.

Authors:  Judith Korner; Marc Bessler; L J Cirilo; Irene M Conwell; Amna Daud; Nancy L Restuccia; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

5.  The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men.

Authors:  Jean L Chan; Kathleen Heist; Alex M DePaoli; Johannes D Veldhuis; Christos S Mantzoros
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

6.  Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects.

Authors:  Jean L Chan; John Bullen; Jennifer H Lee; Nikos Yiannakouris; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

7.  Leptin hormonal kinetics in the fed state: effects of adiposity, age, and gender on endogenous leptin production and clearance rates.

Authors:  Shekman L Wong; Alex M DePaoli; Jennifer H Lee; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

9.  Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty.

Authors:  Mercedes Alvarez Bartolomé; María Borque; Javier Martinez-Sarmiento; Eugenio Aparicio; Carmen Hernández; Lucio Cabrerizo; J A Fernández-Represa
Journal:  Obes Surg       Date:  2002-06       Impact factor: 4.129

10.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

View more
  17 in total

1.  Gastrointestinal hormonal responses on GPR119 activation in lean and diseased rodent models of type 2 diabetes.

Authors:  S Patel; O J Mace; I R Tough; J White; T-A Cock; U Warpman Berglund; M Schindler; H M Cox
Journal:  Int J Obes (Lond)       Date:  2014-01-23       Impact factor: 5.095

2.  Stress-induced release of GUT peptides in young women classified as restrained or unrestrained eaters.

Authors:  Esther Hilterscheid; Reinhold Laessle
Journal:  Eat Weight Disord       Date:  2015-03-18       Impact factor: 4.652

3.  Postprandial ghrelin and PYY responses of male subjects on low carbohydrate meals to varied balancing proportions of proteins and fats.

Authors:  Dalia El Khoury; Rola El-Rassi; Sami Azar; Nahla Hwalla
Journal:  Eur J Nutr       Date:  2010-04-16       Impact factor: 5.614

4.  Changes in levels of peripheral hormones controlling appetite are inconsistent with hyperphagia in leptin-deficient subjects.

Authors:  Sadia Saeed; Paul R Bech; Tayyaba Hafeez; Rabail Alam; Mario Falchi; Mohammad A Ghatei; Stephen R Bloom; Muhammad Arslan; Philippe Froguel
Journal:  Endocrine       Date:  2013-07-04       Impact factor: 3.633

Review 5.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

6.  Effect of weight loss by a low-fat diet and a low-carbohydrate diet on peptide YY levels.

Authors:  P A Essah; J R Levy; S N Sistrun; S M Kelly; J E Nestler
Journal:  Int J Obes (Lond)       Date:  2010-03-30       Impact factor: 5.095

7.  Differential secretion of satiety hormones with progression of obesity in JCR:LA-corpulent rats.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Obesity (Silver Spring)       Date:  2008-01-24       Impact factor: 5.002

8.  Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats.

Authors:  Suraj Unniappan; Timothy J Kieffer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-16       Impact factor: 3.619

9.  Examining acute and chronic effects of short- and long-chain fatty acids on peptide YY (PYY) gene expression, cellular storage and secretion in STC-1 cells.

Authors:  Katharine V Hand; Christine M Bruen; Fiona O'Halloran; Harsh Panwar; Danielle Calderwood; Linda Giblin; Brian D Green
Journal:  Eur J Nutr       Date:  2012-08-28       Impact factor: 5.614

10.  Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss.

Authors:  Thomas Reinehr; Christian L Roth; Gerit-Holger Schernthaner; Hans-Peter Kopp; Stefan Kriwanek; Guntram Schernthaner
Journal:  Obes Surg       Date:  2007-11-29       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.